| Patents for A61K 38 - Medicinal preparations containing peptides (316,240) |
|---|
| 09/21/1989 | WO1989008461A1 Interferon gamma composition to suppress immune system |
| 09/21/1989 | WO1989008460A1 Antibodies for use in antilymphocyte antibody therapy |
| 09/21/1989 | WO1989008458A1 Endocrine manipulation to improve body composition of poultry |
| 09/21/1989 | WO1989008456A1 Inhibition of intestinal cholesterol and fatty acid absorption |
| 09/21/1989 | WO1989008449A1 Method of potentiating an immune response and composition therefor |
| 09/21/1989 | WO1989008441A1 Composition inducing a binding |
| 09/21/1989 | DE3808141A1 Composition for controlling migraine |
| 09/20/1989 | EP0333574A2 Human nerve growth factor |
| 09/20/1989 | EP0333523A2 Method of potentiating an immune response and compositions therefor |
| 09/20/1989 | EP0333517A2 Method and agent for inhibiting the binding of human polymorphonuclear leukocytes to endothelium and compositions therefor |
| 09/20/1989 | EP0333490A2 Composition for the treatment of hepatopathy |
| 09/20/1989 | EP0333474A2 Process for the selective removal of endotoxin |
| 09/20/1989 | EP0333438A2 Novel derivative of human growth hormone |
| 09/20/1989 | EP0333356A2 Hirudin peptides |
| 09/20/1989 | EP0333349A2 Phenethanolamine and growth hormone combinations |
| 09/20/1989 | EP0333201A2 Human heat shock factor |
| 09/20/1989 | EP0333174A2 Peptide compounds, processes for preparation thereof and pharmaceutical composition comprising the same |
| 09/20/1989 | EP0333134A2 Gentechnological preparation of protein PP 15. |
| 09/20/1989 | EP0333071A2 Polypeptides, methods for their preparation, pharmaceutical compositions comprising them and use |
| 09/20/1989 | EP0333000A2 Peptides with inhibitory activity of enzymatic systems, process for their preparation and pharmaceutical compositions containing them |
| 09/20/1989 | EP0332999A2 Peptides with inhibitory activity of enzymatic systems, process for their preparation and pharmaceutical compositions containing them |
| 09/20/1989 | EP0332985A2 Method of purification of factor XII by affinity chromatography |
| 09/20/1989 | EP0332952A2 Polysulfated heparin combinations against retrovirus infections |
| 09/20/1989 | EP0332912A2 Inhibition of cell migration with synthetic peptides |
| 09/20/1989 | EP0332879A2 Monoclonal antibody recognizing un-natural ganglioside GD3 |
| 09/20/1989 | EP0332865A2 Suppression of B-cells in mammals |
| 09/20/1989 | EP0332688A1 Bradykinin antagonist peptides |
| 09/20/1989 | EP0332678A1 Micro-size fibrinolytic plasmin |
| 09/20/1989 | EP0332667A1 Vector for integration site independent gene expression in mammalian host cells |
| 09/20/1989 | EP0332640A1 Recombinant alzheimer's amyloid protein |
| 09/20/1989 | CN1035619A Human relaxin formulation |
| 09/19/1989 | US4868313 A process for making pyrrolidone derivatives |
| 09/19/1989 | US4868312 Intermediate for angiotensin converting enzyme inhibitor |
| 09/19/1989 | US4868285 Antibiotic production |
| 09/19/1989 | US4868212 Pharmaceutical and dietary composition |
| 09/19/1989 | US4868171 Antibiotic A 40926 N-acylaminoglucuronyl aglycons and antiobiotic A 40926 aglycon |
| 09/19/1989 | US4868157 Immunology |
| 09/19/1989 | US4868156 Treatment of skin disorders |
| 09/19/1989 | US4868155 Immune system stimulants |
| 09/19/1989 | US4868154 Stimulation of tear secretion with melanocyte stimulating hormones |
| 09/19/1989 | US4868119 Hematopoietic growth factors |
| 09/19/1989 | US4868116 Introduction and expression of foreign genetic material in epithelial cells |
| 09/19/1989 | US4868113 Recombinant DNA vector encoding human endothelial cell growth factor |
| 09/19/1989 | US4868112 Novel procoagulant proteins |
| 09/19/1989 | US4867962 Anticancer, mixtures of binding patterns to increase amount at target site |
| 09/19/1989 | EP0290504A4 A cDNA CLONE FOR HUMAN TYROSINASE. |
| 09/19/1989 | EP0267275A4 A DNA SEQUENCE ENCODING THE -i(ROS) ONCOGENE, POLYPEPTIDES ENCODED THEREFROM, AND DIAGNOSTIC AND OTHER METHODS BASED THEREON. |
| 09/19/1989 | CA1259750A1 Muramylpeptide lipophilic derivatives activating macrophages, compositions comprising same and process for obtaining them |
| 09/13/1989 | EP0332576A2 Modified proteins |
| 09/13/1989 | EP0332523A1 Hirudin variants, their use and process for their preparation |
| 09/13/1989 | EP0332464A2 Superoxide dismutase polypeptides in the prevention of metastasis of malignant tumour cells |
| 09/13/1989 | EP0332369A2 Antibiotic |
| 09/13/1989 | EP0332346A2 Pharmaceutical combinations containing a piperidinylcyclopentylheptenoic acid derivative |
| 09/13/1989 | EP0332225A2 Antibody to polypeptides complementary to peptides or proteins having an amino acid sequence or nucleotide coding sequence at least partially known and methods of design therefor |
| 09/13/1989 | EP0332222A2 Intravaginal delivery of biologically active polypeptides |
| 09/13/1989 | EP0332174A2 Cell specific cytotoxic agents |
| 09/13/1989 | EP0332022A2 Magnetic protein conjugates, process for their production and their use |
| 09/13/1989 | EP0332008A2 Peptide-like aminoacid derivatives |
| 09/13/1989 | EP0331934A1 New pharmaceutical compositions containing thymosin alpha 1 |
| 09/13/1989 | EP0331821A1 Antiviral agent |
| 09/13/1989 | EP0331803A2 Medicament for inhibiting onset of or treating migraine headaches employing an ace inhibitor |
| 09/13/1989 | EP0331756A1 Agents for prophylaxis and treatment of thrombopenia |
| 09/13/1989 | EP0331743A1 Protein derived from living body |
| 09/13/1989 | CN1035526A Vectors and compounds for expression of zymogen forms of human protein c |
| 09/12/1989 | US4866206 Inhibitors of ornithine decarboxylase |
| 09/12/1989 | US4866160 Therapeutic decapeptides |
| 09/12/1989 | US4866040 Aminocarnitine directed pharmaceutical agents |
| 09/12/1989 | US4866039 Peptides containing the 18 to 23 residues of vasoactive intestinal peptide, and analogues |
| 09/12/1989 | US4866038 Method of stimulating integumental melanocytes by topical application of analogs of alpha-msh |
| 09/12/1989 | US4866037 Polypeptide factors from colostrum |
| 09/12/1989 | US4866036 Enhance resistance to opportunistic infections in combination with aids viricide |
| 09/12/1989 | US4866035 Dipeptidyl saccharides as host resistance enhancers in AIDS-immuno-compromised hosts and methods of use |
| 09/12/1989 | US4866033 Oligopeptides from bovine blood |
| 09/12/1989 | CA1259449A1 Serum thymic factor peptide analogs and a process for the preparation thereof |
| 09/08/1989 | WO1989008255A1 Carcinoma orosomucoid-related antigen, a monoclonal antibody thereto, and their uses |
| 09/08/1989 | WO1989008254A1 Germ cell alkaline phosphatase gene and protein produced thereby |
| 09/08/1989 | WO1989008143A1 Derivatives of soluble t-4 |
| 09/08/1989 | WO1989008118A1 Synthetic scm-active cancer recognition peptides |
| 09/08/1989 | WO1989008114A1 Rapid immunoselection cloning method |
| 09/08/1989 | WO1989007949A1 Monoclonal antibody against bone alkaline phosphatase |
| 09/08/1989 | WO1989007948A1 Antihypertensive hyperimmune milk, production, composition, and use |
| 09/08/1989 | WO1989007947A1 Improvements relating to antigens |
| 09/08/1989 | WO1989007945A1 Human relaxin formulation |
| 09/08/1989 | WO1989007944A1 Device for site directed neovascularization and method for same |
| 09/08/1989 | WO1989007940A1 1,2-hydroxy phosphonates and derivatives thereof |
| 09/08/1989 | WO1989007938A1 Fatty acid-drug conjugate for delivery of the drug across the blood-brain barrier |
| 09/08/1989 | WO1989007934A1 Twin-chamber syringe filled with a charge of activity-sensitive human protein as active substance |
| 09/06/1989 | EP0331640A2 Use of an interleukin-6 molecule in inhibiting bone resorption |
| 09/06/1989 | EP0331635A2 Preparations for treating bladder cancer |
| 09/06/1989 | EP0331630A1 Use of IGF-I for the manufacture of a preparation for treating and preventing secondary effects of hyperinsulinemia in diabetics treated with insulin |
| 09/06/1989 | EP0331609A2 Angiotensin converting enzyme inhibitors having psychotropic effects |
| 09/06/1989 | EP0331186A2 Monoclonal antibody selectively binding to novel g-csf derivative |
| 09/06/1989 | EP0331152A1 Two-component syringe with a filling of sensitive human protein as the active ingredient |
| 09/06/1989 | EP0331105A2 1,2-Hydroxy phosphonates and derivatives thereof |
| 09/06/1989 | EP0331088A2 Remedy for hematopoietic tissue diseases comprising human monocytic macrophage colony stimulating factor as active ingredient |
| 09/06/1989 | EP0331034A2 Functionally specific antibodies |
| 09/06/1989 | EP0331014A2 Use of ACE inhibitors in diabetes prophylaxis |
| 09/06/1989 | EP0330925A2 Renin-inhibiting amino acid derivatives |
| 09/06/1989 | EP0330923A2 Nikkomycin derivatives, antimycotic compositions of nikkomycin derivatives and azole antimycotics |
| 09/06/1989 | EP0330801A1 Ferromagnetic, diamagnetic or paramagnetic particles useful in the diagnosis and treatment of disease |